Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

Lior mor

355 POSTS

Exclusive articles:

SKN | Alamar Biosciences, Inc. Common Stock: Precision Proteomics Play Enters IPO Pipeline Amid Biotech Funding Reset

Alamar Biosciences, Inc. is preparing for its initial public offering of common stock, targeting approximately $8 million US in gross proceeds as it looks...

SKN | Firefly Aerospace Jumps 17% as Space Launch Demand Momentum Drives Stock Repricing

Shares of Firefly Aerospace Inc. surged 17.41%, closing at $44.17, as investors rotated back into high-growth aerospace and space technology names. The move marks...

SKN | JPMorgan Fundamental Data Science Large Value ETF: Data-Driven Equity Strategy Targets Value Rotation

JPMorgan is preparing to bring its Fundamental Data Science Large Value ETF to market with an initial public offering targeting approximately $8 million US...

SKN | IonQ Surges as Quantum Computing Momentum Drives Investor Interest

Shares of IonQ, Inc. (NYSE: IONQ) climbed sharply to $43.25, posting a 20.95% gain in the latest session and extending a powerful short-term rally....

SKN | Wipro Faces Growth Pressure as Earnings Near Amid Weak Long-Term Performance

Modest Short-Term Gains Mask Broader Weakness Shares of Wipro Limited (NYSE: WIT) rose to $2.27, gaining 2.71% in the latest session. While the move reflects...

Breaking

SKN | Geothermal Developer Fervo Energy Files for Estimated $250 Million IPO

Fervo Energy, a next-generation geothermal energy developer, has filed...

SKN | Mobia Medical Files for $100M IPO as Neurostimulation Therapy Targets $30B Stroke Market

FDA-Approved Device Positions Company in High-Value Neurorehabilitation Segment Mobia Medical...

SKN | Amatuhi Holdings Raises IPO Range as Investor Demand Lifts Expected Proceeds by 60%

Revised Pricing Signals Stronger Market Interest Ahead of Nasdaq...

SKN | Alamar Biosciences Prices Upsized IPO at $17, the High End of the Range

Alamar Biosciences has priced its upsized initial public offering...
spot_imgspot_img